Adenosine preconditions against endothelin-induced constriction of coronary arterioles

Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2593-7. doi: 10.1152/ajpheart.2000.279.6.H2593.

Abstract

Myocardial hypoperfusion is accompanied by concomitant increases in adenosine and endothelin-1 (ET-1) production, but the vasodilatory effect of adenosine prevails over that of ET-1. Therefore, we hypothesized that adenosine-induced or ischemic preconditioning reduces the vasoconstrictive effect of ET-1. Coronary arteriolar diameter in vivo was measured using fluorescence microangiography in anesthetized open-thorax dogs. ET-1 (5 ng. kg(-1). min(-1) administered intracoronary, n = 10) induced progressive constriction over 45 min [25 +/- 6% (SE)]. The constriction was blocked by preconditioning with adenosine (25 microgram. kg(-1). min(-1) administered intracoronary) for 20 min and 10 min of washout (n = 10) or attenuated by ischemic preconditioning (four 5-min periods of ischemia, 9 +/- 5% at 45 min). To investigate the receptor involved in this process, coronary arterioles (50-150 micrometer) were isolated and pressurized at 60 mmHg in vitro. The ET-1 dose-response curve (1 pM-5 nM) was rightward shifted after preconditioning with adenosine (1 microM) for 20 min and 10 min of washout (n = 11). Blockade of A(2) receptors [8-(3-chlorostyryl)caffeine, 1 microM, n = 9] but not A(1) receptors (8-cyclopentyl-1,3-dipropylxanthine, 100 nM, n = 7) prevented this shift. These results suggest that adenosine confers a vascular preconditioning effect, mediated via the A(2) receptor, against endothelin-induced constriction. This effect may offer a new protective function of adenosine in preventing excessive coronary constriction.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine / pharmacology*
  • Animals
  • Arterioles
  • Caffeine / analogs & derivatives*
  • Caffeine / pharmacology
  • Coronary Circulation / drug effects*
  • Coronary Circulation / physiology*
  • Coronary Vessels / drug effects
  • Coronary Vessels / physiology*
  • Dogs
  • Dose-Response Relationship, Drug
  • Endothelin-1
  • In Vitro Techniques
  • Ischemic Preconditioning, Myocardial*
  • Microcirculation / drug effects
  • Microcirculation / physiology
  • Purinergic P1 Receptor Antagonists
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology
  • Vasodilation / drug effects
  • Vasodilation / physiology
  • Vasodilator Agents / pharmacology*
  • Xanthines / pharmacology

Substances

  • Endothelin-1
  • Purinergic P1 Receptor Antagonists
  • Vasodilator Agents
  • Xanthines
  • 8-(3-chlorostyryl)caffeine
  • Caffeine
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Adenosine